The Extended Family of CD1d-Restricted NKT Cells: Sifting Through a Mixed Bag of TCRs, Antigens, and Functions
Overview
Authors
Affiliations
Natural killer T (NKT) cells comprise a family of specialized T cells that recognize lipid antigens presented by CD1d. Based on their T cell receptor (TCR) usage and antigen specificities, CD1d-restricted NKT cells have been divided into two main subsets: type I NKT cells that use a canonical invariant TCR α-chain and recognize α-galactosylceramide (α-GalCer), and type II NKT cells that use a more diverse αβ TCR repertoire and do not recognize α-GalCer. In addition, α-GalCer-reactive NKT cells that use non-canonical αβ TCRs and CD1d-restricted T cells that use γδ or δ/αβ TCRs have recently been identified, revealing further diversity among CD1d-restricted T cells. Importantly, in addition to their distinct antigen specificities, functional differences are beginning to emerge between the different members of the CD1d-restricted T cell family. In this review, while using type I NKT cells as comparison, we will focus on type II NKT cells and the other non-invariant CD1d-restricted T cell subsets, and discuss our current understanding of the antigens they recognize, the formation of stimulatory CD1d/antigen complexes, the modes of TCR-mediated antigen recognition, and the mechanisms and consequences of their activation that underlie their function in antimicrobial responses, anti-tumor immunity, and autoimmunity.
Shrestha D, Bahasoan Y, Eggeling C ACS Appl Mater Interfaces. 2024; 16(37):48982-48992.
PMID: 39250321 PMC: 11420866. DOI: 10.1021/acsami.4c07234.
Siewert L, Fromm K, Dehio C, Pinschewer D J Immunol. 2024; 213(5):553-558.
PMID: 38984869 PMC: 11335324. DOI: 10.4049/jimmunol.2400045.
The role of natural killer T cells in liver transplantation.
Zhao W, Li M, Song S, Zhi Y, Huan C, Lv G Front Cell Dev Biol. 2024; 11:1274361.
PMID: 38250325 PMC: 10796773. DOI: 10.3389/fcell.2023.1274361.
Natural Killer T Cell Diversity and Immunotherapy.
Tognarelli E, Gutierrez-Vera C, Palacios P, Pasten-Ferrada I, Aguirre-Munoz F, Cornejo D Cancers (Basel). 2023; 15(24).
PMID: 38136283 PMC: 10742272. DOI: 10.3390/cancers15245737.
Thymus-derived hormonal and cellular control of cancer.
Savino W, Lepletier A Front Endocrinol (Lausanne). 2023; 14:1168186.
PMID: 37529610 PMC: 10389273. DOI: 10.3389/fendo.2023.1168186.